These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 3030863

  • 21. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 22. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned?
    Watada B, Kennedy K, Chan D, Church B, Patriquin M, Shariff F, Evans MF.
    Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462
    [No Abstract] [Full Text] [Related]

  • 23. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE, Markowitz LE, Heath J, Redd SC, Coleman S, Bellini WJ, Sievert A.
    JAMA; 1996 Mar 06; 275(9):704-7. PubMed ID: 8594268
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.
    Scand J Infect Dis; 2003 Mar 06; 35(10):736-42. PubMed ID: 14606613
    [Abstract] [Full Text] [Related]

  • 25. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA.
    Pediatrics; 2007 Mar 06; 119(3):e574-9. PubMed ID: 17332177
    [Abstract] [Full Text] [Related]

  • 26. [Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].
    Rønne T, Trier H.
    Ugeskr Laeger; 1992 Jul 13; 154(29):2014-8. PubMed ID: 1509567
    [Abstract] [Full Text] [Related]

  • 27. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G, Peña B, Marimón JM, Pérez-Trallero E.
    Vaccine; 1996 Apr 13; 14(6):492-4. PubMed ID: 8782345
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B, Smerdel S, Abu Eldan J, Kolić J, Ferdebar M, Kordić D, Mohacek N.
    Lijec Vjesn; 1989 Apr 13; 111(4-5):131-4. PubMed ID: 2770398
    [Abstract] [Full Text] [Related]

  • 30. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS, Brown ML, Xu J, Sullivan BJ, Marshall GS, Nauert B, Matson DO, Silas PE, Schödel F, Gress JO, Kuter BJ, Protocol 014 Study Group for ProQuad.
    Pediatrics; 2006 Feb 13; 117(2):265-72. PubMed ID: 16452343
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 13; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 33. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A, Gerike E.
    Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536
    [Abstract] [Full Text] [Related]

  • 34. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO, Kapustik LA, Fel'dman EV, Ermolovich MA, Svirchevskaia EIu, Titov LP, Zakharenko DF, Belova EIu, Chernovetskiĭ MA, Korostik TS.
    Zh Mikrobiol Epidemiol Immunobiol; 1998 Jan 31; (4):36-40. PubMed ID: 9783398
    [Abstract] [Full Text] [Related]

  • 35. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
    Isozaki M, Kuno-Sakai H, Hoshi N, Takesue R, Takakura I, Kimura M, Hikino M, Mitsuda M.
    Tokai J Exp Clin Med; 1982 Sep 31; 7(5):547-50. PubMed ID: 7182947
    [Abstract] [Full Text] [Related]

  • 36. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Responses to triple viral and tetanus vaccination in HIV-infected children].
    Echeverría Lecuona J, Aldamiz-Echevarría Azuara L, Cilla Eguiluz G, Pérez Trallero E.
    An Esp Pediatr; 1996 Apr 28; 44(4):317-20. PubMed ID: 8849078
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Measles, mumps, and rubella antibodies in vaccinated Baltimore children.
    King JC, Lichenstein R, Feigelman S, Luna C, Permutt TJ, Patel J.
    Am J Dis Child; 1993 May 28; 147(5):558-60. PubMed ID: 8488803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.